Light Mode
Dark Mode
System Mode
Hospital confirms three-patient outbreak tied to contaminated IV fluid; investigation underway and infection control measures implemented.
Three patients at the City General Hospital developed bloodstream infections after receiving the same intravenous fluid on April 22, the hospital’s infectious disease unit reported; one of the infections required intensive care.
The cases were identified during routine surveillance when clinicians noted similar symptoms and laboratory results among the affected patients. All three had received the same lot of IV fluid during separate procedures earlier that day.
Hospital officials notified public health authorities immediately and removed the remaining units of the implicated IV fluid from clinical use. Microbiological testing of patient blood samples and the fluid lot is underway to identify the causative organism and confirm the link.
According to the infectious disease unit, one patient’s condition worsened and was transferred to the intensive care unit for closer monitoring; the other two remain stable and are receiving targeted antibiotic therapy. No deaths have been reported.
The hospital has initiated an internal review of procurement and medication administration protocols and is cooperating with the regional public health agency’s investigation. Staff who handled the fluid are being interviewed and relevant records have been secured.
Pending laboratory results, clinicians have started empirical treatment for potential contaminants consistent with bloodstream infections associated with contaminated infusates. The hospital emphasized that patients who received IV fluids from the same lot are being monitored and contacted as a precaution.
Public health officials will issue guidance based on test outcomes and may recommend broader actions if contamination is confirmed. The hospital said it will provide updates as new information becomes available.